Top Markets
Coin of the day
Moleculin Biotech, Inc. Moleculin Biotech, Inc.

Moleculin Biotech, Inc.

MBRX
Clasificación en acciones #35911
Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company dedicated to... Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company dedicated to advancing therapeutic candidates designed to combat highly aggressive cancers and viral infections. Their primary investigational drug, Annamycin, is currently undergoing Phase 1/2 clinical trials. These trials aim to assess its efficacy against acute myeloid leukemia (AML) that has relapsed or is resistant to prior therapies, as well as malignancies that have spread to the lungs. WP1066, a prominent immune/transcription modulator for the company, is presently in Phase I studies, targeting both adult and pediatric brain tumors, pancreatic cancer, and other types of aggressive malignancies. Further, the firm is developing WP1220, an analog of WP1066, intended for topical application in treating cutaneous T-cell lymphoma. Another compound, WP1122, is under development for glioblastoma multiforme and COVID-19. Moleculin Biotech has established collaboration agreements and partnerships with organizations such as MD Anderson, Animal Life Sciences, LLC, and WPD Pharmaceuticals Sp z.o.o. The company was founded in 2015 and maintains its principal offices in Houston, Texas.
Precio por acción
$0.6155
Última sincronización: 2026-08-14
Capitalización bursátil
$3.28M
Cambio (1 día)
7.74%
Cambio (1 año)
-96.39%
País
US
Comercio Moleculin Biotech, Inc. (MBRX)

Categoría

Historial del precio de la acción de Moleculin Biotech, Inc. (MBRX)
Precio más alto de cierre: $0.48 el 2026-08-01

Precio más bajo de cierre: $16.17K el 2016-06-01
Historial del precio de la acción de Moleculin Biotech, Inc. desde 2016 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) 8.33%
2025 -90.56%
2024 -77.07%
2023 -51.53%
2022 -36.45%
2021 -59.01%
2020 -17.81%
2019 -15.25%
2018 -35.47%
2017 -12.10%
2016 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE